Company intelligence / Profile preview

Diagnomics

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Diagnomics offers CLIA-certified, CAP-accredited genetic testing and advanced genome analysis services with a focus on personal genome sequencing, bioinformatics, and cloud-based genomics platforms involving NGS, microarray, and PCR. Clinical results are not public, but the company provides validated clinical reporting and precision medicine support to other companies and institutions.

Modalities: Diagnostic testBioinformaticsNext Generation SequencingMicroarrayReal-time PCR
Industry: Molecular Diagnostics

Partnerships

Eone Diagnomics Genome Center (EDGC, South Korea)

Beyond the preview

Go deeper on Diagnomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diagnomics.

Explore the full profile